For this iQ&A CAH Medical Intelligence Zone, can you introduce us to what you plan to discuss, in particular, the new data introduced at ENDO in which more definitive, long-term follow-up data was presented for the CAHtalyst adult and pediatric trials?
Presenter
Professor of Pharmacology and Internal Medicine
Division of Metabolism, Endocrinology, and Diabetes
University of Michigan School of Medicine
Ann Arbor, Michigan
